How is retatrutide administered
Weight loss typically begins within the first few weeks of Zepbound treatment, but most patients do not reach therapeutic maintenance doses until 16-24 weeks into treatment
What this is Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist that works on two separate hunger-regulating pathways at once
As patients lose substantial amounts of adipose tissue, their body's natural insulation decreases, potentially making them more susceptible to environmental temperature changes
Some insurance plans may not cover the full cost, leading to higher out-of-pocket expenses
Such off-label use, i.e., made in the absence of an FDA approval for this indication, in itself is reason for carefully conducted, evidence-based clinical trials, say the researchers, who reported results in JAMA Psychiatry